Bell Steven, Daskalopoulou Marina, Rapsomaniki Eleni, George Julie, Britton Annie, Bobak Martin, Casas Juan P, Dale Caroline E, Denaxas Spiros, Shah Anoop D, Hemingway Harry
Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge CB1 8RN, UK
Research Department of Epidemiology and Public Health, University College London, London WC1E 7HB, UK.
BMJ. 2017 Mar 22;356:j909. doi: 10.1136/bmj.j909.
To investigate the association between alcohol consumption and cardiovascular disease at higher resolution by examining the initial lifetime presentation of 12 cardiac, cerebrovascular, abdominal, or peripheral vascular diseases among five categories of consumption. Population based cohort study of linked electronic health records covering primary care, hospital admissions, and mortality in 1997-2010 (median follow-up six years). CALIBER (ClinicAl research using LInked Bespoke studies and Electronic health Records). 1 937 360 adults (51% women), aged ≥30 who were free from cardiovascular disease at baseline. 12 common symptomatic manifestations of cardiovascular disease, including chronic stable angina, unstable angina, acute myocardial infarction, unheralded coronary heart disease death, heart failure, sudden coronary death/cardiac arrest, transient ischaemic attack, ischaemic stroke, intracerebral and subarachnoid haemorrhage, peripheral arterial disease, and abdominal aortic aneurysm. 114 859 individuals received an incident cardiovascular diagnosis during follow-up. Non-drinking was associated with an increased risk of unstable angina (hazard ratio 1.33, 95% confidence interval 1.21 to 1.45), myocardial infarction (1.32, 1.24 to1.41), unheralded coronary death (1.56, 1.38 to 1.76), heart failure (1.24, 1.11 to 1.38), ischaemic stroke (1.12, 1.01 to 1.24), peripheral arterial disease (1.22, 1.13 to 1.32), and abdominal aortic aneurysm (1.32, 1.17 to 1.49) compared with moderate drinking (consumption within contemporaneous UK weekly/daily guidelines of 21/3 and 14/2 units for men and women, respectively). Heavy drinking (exceeding guidelines) conferred an increased risk of presenting with unheralded coronary death (1.21, 1.08 to 1.35), heart failure (1.22, 1.08 to 1.37), cardiac arrest (1.50, 1.26 to 1.77), transient ischaemic attack (1.11, 1.02 to 1.37), ischaemic stroke (1.33, 1.09 to 1.63), intracerebral haemorrhage (1.37, 1.16 to 1.62), and peripheral arterial disease (1.35; 1.23 to 1.48), but a lower risk of myocardial infarction (0.88, 0.79 to 1.00) or stable angina (0.93, 0.86 to 1.00). Heterogeneous associations exist between level of alcohol consumption and the initial presentation of cardiovascular diseases. This has implications for counselling patients, public health communication, and clinical research, suggesting a more nuanced approach to the role of alcohol in prevention of cardiovascular disease is necessary. clinicaltrails.gov (NCT01864031).
通过检查五类饮酒情况中12种心脏、脑血管、腹部或外周血管疾病的首次终生发病情况,以更高分辨率研究饮酒与心血管疾病之间的关联。基于人群的队列研究,链接了1997 - 2010年的电子健康记录,涵盖初级保健、住院和死亡率(中位随访6年)。CALIBER(使用链接定制研究和电子健康记录的临床研究)。1937360名成年人(51%为女性),年龄≥30岁,基线时无心血管疾病。12种常见的心血管疾病症状表现,包括慢性稳定型心绞痛、不稳定型心绞痛、急性心肌梗死、未被察觉的冠心病死亡、心力衰竭、心源性猝死/心脏骤停、短暂性脑缺血发作、缺血性中风、脑内和蛛网膜下腔出血、外周动脉疾病和腹主动脉瘤。114859人在随访期间被诊断为新发心血管疾病。与适度饮酒(分别符合英国当时男性每周/每日21/3单位、女性14/2单位的指南)相比,不饮酒与不稳定型心绞痛(风险比1.33,95%置信区间1.21至1.45)、心肌梗死(1.32,1.24至1.41)、未被察觉的冠心病死亡(1.56,1.38至1.76)、心力衰竭(1.24,1.11至1.38)、缺血性中风(1.12,1.01至1.24)、外周动脉疾病(1.22,1.13至1.32)和腹主动脉瘤(1.32,1.17至1.49)的风险增加相关。重度饮酒(超过指南)会增加未被察觉的冠心病死亡(1.21,1.08至1.35)、心力衰竭(1.22,1.08至1.37)、心脏骤停(1.50,1.26至1.77)、短暂性脑缺血发作(1.11,1.02至1.37)、缺血性中风(1.33,1.09至1.63)、脑内出血(1.37,1.16至1.62)和外周动脉疾病(1.35;1.23至1.48)的风险,但心肌梗死(0.88,0.79至1.00)或稳定型心绞痛(0.93,0.86至1.00)的风险较低。饮酒水平与心血管疾病的首次发病之间存在异质性关联。这对患者咨询、公共卫生宣传和临床研究具有启示意义,表明有必要对酒精在预防心血管疾病中的作用采取更细致入微的方法。clinicaltrails.gov(NCT01864031)